Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

IMPORTANCE: Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19). However, there are limited data on efficacy and associated adverse events. OBJECTIVE: To describe the association between use of hy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA
Päätekijät: Rosenberg, Eli S., Dufort, Elizabeth M., Udo, Tomoko, Wilberschied, Larissa A., Kumar, Jessica, Tesoriero, James, Weinberg, Patti, Kirkwood, James, Muse, Alison, DeHovitz, Jack, Blog, Debra S., Hutton, Brad, Holtgrave, David R., Zucker, Howard A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2020
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7215635/
https://ncbi.nlm.nih.gov/pubmed/32392282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.8630
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia